BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Garbuzenko DV, Arefyev NO, Kazachkov EL. Antiangiogenic therapy for portal hypertension in liver cirrhosis: Current progress and perspectives. World J Gastroenterol 2018; 24(33): 3738-3748 [PMID: 30197479 DOI: 10.3748/wjg.v24.i33.3738]
URL: https://www.wjgnet.com/1007-9327/full/v24/i33/3738.htm
Number Citing Articles
1
Н. Р. Матковська. Analysis of Causes of Death in Patients with Alcoholic Liver Cirrhosis Associated with Non-alcoholic Fatty Liver DiseaseFamily Medicine 2019; 0(4): 47 doi: 10.30841/2307-5112.4.2019.184588
2
Wolfgang Kreisel, Denise Schaffner, Adhara Lazaro, Jonel Trebicka, Irmgard Merfort, Annette Schmitt-Graeff, Peter Deibert. Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal HypertensionInternational Journal of Molecular Sciences 2020; 21(17): 6223 doi: 10.3390/ijms21176223
3
Dmitry Victorovich Garbuzenko, Nikolay Olegovich Arefyev. Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis: An update and review of the literatureJournal of Evidence-Based Medicine 2020; 13(4): 313 doi: 10.1111/jebm.12407
4
Hui Li. Angiogenesis in the progression from liver fibrosis to cirrhosis and hepatocelluar carcinomaExpert Review of Gastroenterology & Hepatology 2021; 15(3): 217 doi: 10.1080/17474124.2021.1842732
5
Hong Zhou, Han Hu, Maoyong Tian, Jun Chu, Caiyun Tian, Yanqing Yang, Shide Lin, Chiara Ricci. Validation and Refinement of the Baveno VI Criteria for Ruling Out High-Risk VaricesGastroenterology Research and Practice 2020; 2020: 1 doi: 10.1155/2020/4217512
6
Xingyao Hu, Guangbin Shang, Jie Zhang, Zhong Chen, Liu Fu, Jun Li, Xiaonan Lu. Clinical Yi-guan decoction for liver cirrhosisMedicine 2021; 100(13): e24530 doi: 10.1097/MD.0000000000024530
7
Chalermrat Bunchorntavakul, K. Rajender Reddy. Pharmacologic Management of Portal HypertensionClinics in Liver Disease 2019; 23(4): 713 doi: 10.1016/j.cld.2019.06.004
8
Sigita Gelman, Violeta Salteniene, Andrius Pranculis, Jurgita Skieceviciene, Romanas Zykus, Dalius Petrauskas, Limas Kupcinskas, Ali Canbay, Alexander Link, Juozas Kupcinskas. Plasma Nogo-A and placental growth factor levels are associated with portal hypertension in patients with liver cirrhosisWorld Journal of Gastroenterology 2019; 25(23): 2935-2946 doi: 10.3748/wjg.v25.i23.2935
9
N. R. Matkovska. MORTALITY ANALYSIS OF THE PATIENTS WITH ALCOHOLIC LIVER CIRRHOSISInternational Journal of Medicine and Medical Research 2019; 5(1): 40 doi: 10.11603/ijmmr.2413-6077.2019.1.9857